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INTRODUCTION 
Problems related to growth of domestic animals have attracted much 
attention during the past few years. It is well known that progress in 
nutrition and selection of domestic animals have greatly improved their 
growth and efficiency of feed conversion which are important in live­
stock production. Additional progress in the future will require a 
better knowledge of growth and the factors affecting the physiological 
processes involved in growth and development. 
In animal production, the interest is in directing the nutrients given 
an animal towards the formation of a particular product such as muscle, 
wool, milk or the functions involved with reproduction. Therefore, 
the hormones which regulate the chemical reactions of the body become 
important controlling factors in these processes. Since growth, to a 
large extent, is controlled by the endocrine system, it would be desirable 
to be able to study the various hormonal factors which regulate the growth 
processes. 
The experimental biologist would be better able to evaluate the endocrine 
aspects of growth if more reliable assay methods were developed for the 
quantitative determination of the hormones present in biological fluids. 
At the present time, inadequate methods are available for the assay of 
blood for the hormones involved with growth. There appear to be two 
general approaches which could be used to measure the circulating hormones. 
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One is an indirect approach which has been briefly investigated and 
involves the measurement of a substance in blood which may be related 
with or dependent on the concentration of a circulating hormone. The 
other is the more direct approach which would be to actually measure 
the circulating hormone per se. It is obvious that the direct approach 
would be more satisfactory. However, if the details of such a technique 
are too involved for application to large numbers of domestic animals 
it might best be used only in a limited way such as for standardization 
of an indirect method. 
Since it appears that a direct method for measuring hormones in 
blood is needed before indirect studies could be made, it was the purpose 
of this investigation to develop a method which could be used to assay 
blood for growth hormone per se. It is known that other hormones 
such as those originating from the adrenal and thyroid glands are 
involved in the growth process, but since growth hormone has the most 
profound effect upon growth of the whole animal body, it seemed logical 
to make initial studies with this hormone. Also in the present study, 
only bovine blood was made use of in the procedures investigated. 
The concentration of growth hormone in bovine plasma is too small 
to be measured accurately with available conventional methods of assay. 
The most accurate conventional method of assay is the tibia test in 
hypophysectomized rats. This method has proved satisfactory in 
measuring growth hormone in tissues relatively concentrated in the 
3 
hormone such as the anterior pituitary gland. Nevertheless the 
sensitivity of this method is not sufficiently great to measure the minute 
amount of growth hormone circulating in the blood. Therefore in the 
present study an attempt was made to concentrate different blood plasma 
fractions so that the growth hormone content would be sufficiently high 
that it could be reliably measured by the tibia test. 
A second method of assay employed in these studies was an immuno­
logical technique. This technique was based upon the observation that 
bovine growth hormone is antigenic when injected into rabbits. The 
sensitivity of immunological methods suggested a possible means for 
quantitatively measuring the minute quantities of growth hormone in 
bovine plasma. In developing this immunological method as well as the 
tibia assay method, one method was compared against the other as a 
means of appraising their reliabilities. 
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REVIEW OF LITERATURE 
Some differences in terminology are present in the literature on growth 
hormone. The term most often used is growth hormone, which was 
initially proposed before the hormone was isolated as a pure substance. 
After isolation and characterization of the hormone from the anterior 
pituitary, the name somatotropin was suggested rather than the more 
vague term growth hormone. The term often seen in papers dealing 
with studies on the circulating hormone is growth-promoting substances 
which leaves some question as to what was being measured. 
The author is very much in favor of adopting consistent terminology 
and has a tendency to favor somatotropin when referring to the purified 
pituitary preparation, but after some consideration, growth hormone 
was used to designate the hormone in this manuscript. Since there is 
no definite evidence that the pituitary hormone and the circulating hor­
mone are chemically identical, growth hormone seemed to be the best 
choice. It also appeared desirable to be consistent throughout the man­
uscript rather than confusing the reader with differences in terminology. 
Observations on the Circulating Growth Hormone 
Attempts to estimate the amount of circulating growth horome have 
included measurements of growth hormone activity in whole serum or 
fractions of serum and measurements of substances correlated with the 
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concentration of circulating hormone. 
Reifenstein et al. (43) reported that serum inorganic phosphorus 
levels were increased without a corresponding fall in serum calcium 
levels in acromegalic patients and in growing children as compared to 
normal adults. These workers proposed the use of serum inorganic 
phosphorus level as an index of circulating growth hormone activity. 
More recently, Daughaday et al. (10) have observed that a sulfation 
factor in normal rat serum is a growth hormone -dependent component. 
The sulfation factor disappears from the serum of hypophysectomized 
rats but is present in the serum of those rats treated with growth hor­
mone. An assay technique was developed from the principle that the 
sulfate uptake of costal cartilage from hypophyse ctomized rats is pro­
portional to the amount of serum added to the incubation medium. Serum 
from children promoted greater uptake as compared with serum from 
adults. Serum from a hypophyse ctomized patient showed very little 
activity while that from acromegalic patients had a high activity. 
Kins ell et al. (31) used the rat tibia test to assay serum from an 
acromegalic patient and observed an increase in the epiphyseal cartilage 
width with a dose of 200 milligrams of lyophilized serum. However, 
comparable amounts of serum from a normal patient did not stimulate 
the cartilage width. Greenspan (21)found no growth hormone activity with 
the tibia assay technique by injecting plasma from growing children, 
adults or patients with acromegaly. Albumin and globulin fractions of 
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human serum were also assayed and found not to contain growth hormone 
activity. 
Cotes and Young (9) assayed the globulin fraction of human serum 
which is insoluble in 50 percent saturated ammonium sulfate. Samples 
equal to six to ten milliliters of plasma did not give a response with the 
rat tibia assay. Added growth hormone was only partially recovered 
in this study. 
Plasma samples from several species were fractionated with cold 
ethanol and adjustment of pH and assayed for growth hormone activity 
with the tibia test (19). Growth hormone activity was demonstrated in 
normal plasma from humans, pigs and a calf. There was only about 
25 percent recovery of bovine growth hormone added to the plasma 
samples by this fractionation technique. Gemzell (18) has recently 
fractionated human plasma by precipitating the plasma proteins with 
tricholoroacetic acid, extracting the precipitate with cold absolute ethanol 
and adjusting the pH of the alcohol extract to 6. 1 to obtain the plasma 
fraction. No growth hormone activity was found in normal human serum, 
but some activity was found in serum from an acromegalic patient and 
nearly 100 percent of added human growth hormone could be recovered 
by assaying this fraction in hypophysectomized rats. This technique has 
also been used to demonstrate an increase in plasma levels of growth hor­
mone in patients with diabetes mellitus, liver diseases and hypercholes­
terolemia (16). 
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Read (41) has used a hemagglutination-inhibition technique with an 
antibody to human growth hormone for assaying serum. Serum growth 
hormone levels were found to vary between 0.16 and 0.64 micrograms 
per milliliter. No differences were observed in serum levels in children 
or adults, but a level of 1.2 micrograms per milliliter was observed in 
an acromegalic patient. 
Contopoulos and Simpson (8) injected whole serum from normal rats 
into hypophyse ctomized rats to assay circulating growth hormone. Nor­
mal rat serum contained amounts equivalent to 1. 0 to 2. 5 micrograms 
of purified bovine growth hormone per milliliter while serum from 
pregnant rats contained amounts equivalent to 3.5 to 7.5 micrograms per 
milliliter. 
Nellor (37) and Felch and Nellor (13) fractionated plasma from dairy 
cattle with a cold ethanol procedure. The tibia assay of these fractions 
indicated that plasma from young bulls contained 98 to 121 micrograms 
of growth hormone per 100 milliliters while that from mature bulls con­
tained 4 to 8 micrograms per 100 milliliters. Growth hormone activity 
was found in a plasma fraction which was similar to Cohn fraction II plus 
III. 
Very little information is available on the nature of the circulating 
growth hormone. Heijkenskjold and Gemzell (27) labeled bovine growth 
hormone with 1*^1 and added it to human serum. Electrophoretic patterns 
at pH 10 indicated that the bovine growth hormone traveled with the alpha-2 
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globulin region of the serum proteins. There was no indication that the 
added growth hormone had reacted with the serum proteins. 
Immunological Investigations on Pituitary Growth Hormone 
The initial studies on the antigenicity of growth hormone arose from 
two interests, the first being the homogeneity of the hormone protein and 
the second from attempts to explain the diminishing response resulting 
from prolonged injections of the hormone and the generally poor results 
obtained with the use of the bovine hormone in humans. Elberg and Li 
(12) injected from 4 to 60 milligrams of a crystalline bovine growth hor­
mone dissolved in saline into rabbits and could detect only a very low 
antibody titer with the precipitin test. An alum precipitate of the hor­
mone was also used as an antigen but gave no evidence of stimulating 
antibody production. 
Morrison et al. (36) obtained a low titer antiserum in rabbits by in­
jecting a saline solution of bovine growth hormone; however, there was 
considerable cross-reaction with several beef tissue extracts. Heijken-
skjold and Gemzell (26) injected a saline solution of human growth hormone 
into rats, rabbits and guinea pigs but no antibodies could be detected in 
sera from these animals. 
A high antibody titer to crude bovine pituitary extracts was produced 
in sheep (14), but the specificity of the antibodies to growth hormone was 
questionable since crude extracts were used as antigens. 
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Hayashida and Li have used precipitin ring tests, anaphylactic shock 
experiments and antihormone bioassays to demonstrate the production 
of a specific antibody against bovine growth hormone (25), and human 
growth hormone (24). Papkoff et al. (39) have also produced an anti­
serum with porcine growth hormone. The success of the California 
workers apparently was a result of the use of the adjuvant developed by 
Freund et al. (17). There were some cross-reactions with serum gamma­
globulins and lactogenic hormone, however; these cross reacting anti­
bodies could be absorbed from the antiserum leaving specific antibodies 
for growth hormone. Precipitin ring tests indicated that the bovine 
antiserum would give a positive reaction with one microgram of purified 
bovine growth hormone (25) while the human growth hormone antiserum 
would give a positive reaction with 0.1 microgram of purified human or 
monkey growth hormone (24). 
Fishman et al. (15) studied the antigenicity of human, bovine and 
porcine growth hormone preparations by injection with the Freund adjuvant 
into rabbits. Hemagglutination-inhibition tests indicated that high titer 
antisera for all of these hormones were produced and that the antibodies 
were hormone specific as well as species specific. Hayashida and Li 
(23) made a comparative immunological study of growth hormone from 
several species. The bovine and ovine growth hormones gave similar 
reactions while the human, monkey and whale growth hormones did not 
react with the bovine growth hormone antiserum in precipitin tests or agar 
gel diffus si on studies. The human and monkey hormones also had similar 
immunological properties when allowed to react with human growth hor­
mone antiserum. The porcine hormone antiserum has been shown to 
react with whale growth hormone but not with the human hormone (39). 
The cross-reaction of the hormones from sheep and cattle and from 
humans and monkeys is not unusual since physical chemical data have 
indicated that the bovine and ovine hormones have similar protein 
structure and the human and monkey hormones are similar. 
Data on the use of a specific antiserum to assay serum are somewhat 
limited. Keele et_al. (30) reported that Cohn fraction II plus III was the 
only human serum fraction which would completely precipitate all the 
antibodies against a purified human growth hormone preparation. No 
reaction was obtained with normal human serum or Cohn fraction II plus 
III prepared from the serum of a hypophysectomized girl. 
The hemagglutination-inhibition technique has been used by Read and 
Stone (42) to demonstrate a reaction of human growth hormone with its 
specific antibody. This technique which was used as an assay indicated 
values ranging from 0. 16 to 0.64 micrograms per milliliter of serum 
from normal children and adults. No circulating growth hormone could 
be detected in the serum from two hypophyse ctomized patients. 
Là et al. (33) have standardized the quantitative precipitin test as an 
assay technique for the range from zero to 20 micrograms of purified 
human growth hormone. The technique was used to estimate the growth 
hormone content of human pituitaries with reliable precision and repeat­
ability. However, this method gave slightly higher values than the rat 
tibia test which was run concurrently with the immunochemical assay. 
No reaction could be observed with normal human serum or serum 
from acromegalic patients, but 100 percent of added growth hormone 
could be recovered. It was assumed by the authors that serum levels 
of growth hormone were below one microgram per milliliter. 
The Effect of Growth Hormone on the Growth 
of Domestic Animals 
Many papers have appeared in the literature which have indicated 
that the pituitary gland secretes a protein hormone which has a direct 
influence on general body growth. The papers to be reviewed here are 
concerned only with the effect of growth hormone on growth of domestic 
animals. 
It has generally been assumed that the rates of secretion of the 
glands concerned with growth may be correlated with the performance of 
animals which are not subjected to undue nutritional or disease stress. 
Baird et al. (2) assayed pituitary glands for growth hormone from two 
lines of pigs which had been selected for rapid and slow rates of gain. 
The rapid-line pigs contained significantly more growth hormone per unit 
of pituitary tissue as well as per unit of body weight. The concentration 
of growth hormone per unit of anterior pituitary tissue did not change 
with age of either line. In relation to pituitary size and body weight, 
the amount of growth hormone per unit of body weight increased in the 
rapid-line from 56 to 115 days of age and then decreased, while in the 
slow-line the concentration of hormone increased up to 75 days where 
it remained constant to 154 days and then decreased in the mature 
animal. It appears that in swine the growth hormone secretion per 
unit of pituitary tissue may be constant at all ages but the ratio of 
anterior pituitary weight to body weight decreases with increasing age 
and therefore the concentration of growth hormone in the body as a whole 
decreases. 
Turman and Andrews (48) administered daily injections of 2. 5 to 10 
milligrams of growth hormone per 15 kilograms of body weight to 
growing pigs weighing 100 pounds and continued the injections to about 
220 pounds. The pigs injected with growth hormone gained only slightly 
more but consumed less feed and consequently were much more efficient in 
feed utilization. The injections of growth hormone caused a significant 
increase in blood glucose, a slight increase in blood inorganic phosphorus 
and a decrease in blood non-protein nitrogen. The carcasses of the 
growth hormone injected pigs contained more protein and moisture and 
less fat than the carcasses of the control pigs. Extreme differences 
were observed in the response of individual animals to the hormone prep­
arations (11). Four of the eleven animals treated with the hormone died 
during the experiment. Death occurred within 17 to 45 days, following 
severe muscular trembling and clonic convulsions. 
A study by Armstrong and Hansel (1) indicated that the rate of growth 
of Hoistein heifers during a 16 week period prior to slaughter was 
positively correlated with the concentration of growth hormone per gram 
of anterior pituitary, pituitary growth hormone per 100 pounds of body 
weight and the total thyrotropin content of the pituitaries. The decrease 
in growth hormone per unit of anterior pituitary with increasing age from 
one to 80 weeks was not significant. There was a greater decrease in 
pituitary growth hormone per 100 pounds of body weight with increasing 
age which was similar to that observed in pigs by Baird et al. (2). There 
were no significant differences in the total growth hormone content of 
the bovine pituitaries as a result of levels of nutrition. Marlowe and 
Chambers (35) studied some of the endocrine aspects of dwarfism in 
beef cattle and found indications that the pituitaries from dwarf calves 
contained more growth hormone as compared to normal calves. Brumby 
(4) gave 16 week-old Jersey heifers daily injections of bovine growth hor­
mone at the rate of five milligrams per 100 pounds of body weight for 12 
weeks. The growth hormone treated heifers gained significantly more 
body weight and height at the wethers during the 12 week injection period 
as compared to the controls; however, the control animals gained con­
siderably more during the five week period after the daily injections were 
stopped. 
Clegg and Cole (6) made detailed studies on the growth response from 
stilbestrol administered to beef cattle. In all of these studies, the animals 
treated with stilbestrol contained heavier pituitaries. The growth hormone 
content of stilbestrol treated steer pituitaries was not significantly 
different from the controls, but the pituitaries from treated heifers con­
tained twice as much growth hormone as the control heifers. Further 
studies by Struempler and Burroughs (47) have also shown an increase 
in anterior pituitary weights of steers fed stilbestrol. The growth hor­
mone concentration per gram of pituitary was similar in treated and un­
treated animals but total growth hormone content of pituitaries was 
greater for the treated steers which resulted in more growth hormone 
per pound of body weight. Similar results have been observed by Hinds 
et al. (28). 
Shroder and Hansard (46) studied the effects of stilbestrol in lambs 
and found heavier pituitaries in the treated animals as well as more 
pituitary tissue per unit of body weight. Biological assays indicated 
slightly greater growth hormone content per gram of pituitary for the 
treated lambs. Struempler and Burroughs (47) found an increased 
nitrogen retention in lambs fed two milligrams of stilbestrol per day. 
Similar improvements in nitrogen retention could be shown by the in­
jection of 12.5 milligrams of bovine growth hormone per day. 
Raun (40) assayed anterior pituitary glands from steers fed meth-
imazole ( 1 -methyl, 2-mercapto, imidazol) and found increased levels 
of growth hormone per gram of anterior pituitary. The pituitaries from 
the steers fed the goitrogen were also heavier than those from the 
controls. The addition of 600 milligrams of methimazole to the daily 
ration of steers increased live -weight gains and improved feed efficiency. 
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EXPERIMENTAL AND RESULTS 
Bioassay of Growth Hormone in Bovine Plasma Fractions 
The most important consideration in any quantitative analysis is 
the selection of a technique which is reliable for the conditions under 
which the analysis is to be made. The tibia test (22) which is generally 
used as the standard assay for growth hormone has been thoroughly 
studied and found to be the most reliable assay for growth hormone. 
However, the method is not sensitive enough to detect the growth hor­
mone content of normal plasma (9). The results of Nellor (37) and 
Gemzell et al. (19) indicated that growth hormone in bovine plasma was 
sufficiently concentrated in a plasma protein fraction that it could be 
assayed with the tibia test. The purpose of this part of the study was 
to make extensive plasma fractionation studies to determine if such a 
method would be feasible for estimating the growth hormone content of 
blood plasma. 
Methods 
Bovine plasma was fractionated by the low salt-ethanol method 
originally developed by Cohn et al. (7). In all the fractionation studies, 
the blood was drawn into oxalated receptacles and the blood cells were 
removed by centrifugation. The plasma was immediately cooled in a 
freezer to near 0° C and then moved to a cold room which was maintained 
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at -5 11° C for all subsequent manipulations of the fractionation. In 
all studies, the ethanol concentration was adjusted by the slow addition 
of a 50 percent water-ethanol mixture (v/v at 25° C) through a fine 
capillary jet with sufficient continuous stirring to prevent local con­
centration of ethanol. Ninty-five percent ethanol was used for in­
creasing the ethanol concentration above 30 percent by adding drop wise 
with continuous stirring. 
The pH adjustments were made by adding 4.8 molar acetate buffer 
of pH 4. 0. A Beckman Model H pH meter was used to measure pH values. 
The pH adjustments in the first stages of the fractionation methods were 
usually made by adding the volume of buffer as indicated by Cohn et al. 
(7). 
The precipitates were removed by centrifugation, suspended in a 
small volume of cold distilled water and then dried by lyophilization. 
The plasma protein fractions were stored as the dried lyophilized 
product in the freezer. 
The conditions of the various fractionation methods used are discussed 
in the following paragraphs. 
Method I This procedure was essentially the same as Method 6 
used by Cohn et al. (7) to fractionate human blood plasma. The plasma 
was stirred gently with the addition of the ethanol-water mixture and 
sodium acetate-acetic acid buffer to adjust the pH to 7. 2 and the final 
ethanol concentration to eight percent. The time for this addition was 
approximately 1.5 hours. The precipitate was removed and designated 
as fraction I. The supernatant was next adjusted to pH 6. 9 and 25 per­
cent ethanol over a period of two hours. The precipitate which formed 
was designated fraction II plus III. 
Method II This procedure was developed by Gemzell (18) for 
fractionating human plasma to concentrate human growth hormone. 
The plasma was cooled and treated with an equal volume of ten percent 
trichloroacetic acid. The precipitate was washed three times with five 
percent tricholoroacetic acid and then extracted three times with cold 
absolute ethanol. Each time the volume of the ethanol was the same as 
the original plasma volume. The pH of the combined ethanol extracts 
was adjusted to 6. 1 by the slow addition of 0. 1 N NaOH. The precipitate 
was removed by centrifugation and suspended in pH 9. 0 saline for in­
jection into the assay animals. Since Gemzell (18) could recover nearly 
100 percent of the human growth hormone added to human plasma with 
this procedure, it appeared desirable to study the recovery of added 
bovine growth hormone to bovine plasma. A bovine plasma sample 
was divided into two equal volumes and to one was added 12 micrograms 
of a purified bovine growth hormone preparation per milliliter, prior 
to fractionation. Both plasma samples were then fractionated by 
Method II and the plasma fractions assayed in rats. 
Method III The plasma was cooled to near 0° C and gently stirred 
with the addition of the ethanol-water mixture and the acetate buffer to 
adjust the pH to 7.2 and the ethanol concentration to 18 percent over a 
period of approximately 1. 5 hours. The precipitate was removed by 
centrifugation and discarded. The pH was lowered to 6. 9 and the ethanol 
concentration increased to 25 percent with constant stirring over a 
period of one hour. The precipitate was designated as fraction B-l. 
The pH of supernatant B-l was measured and adjusted to 5. 2 and the 
ethanol concentration decreased to 18 percent by adding cold water 
with gentle stirring for one hour. The mixture was allowed to stand 
for eight to ten hours in the cold room and the precipitate was removed 
by centrifugation and designated as fraction B-2. Fraction B-l and 
B-2 were combined before lyophilizing and designated as fraction B. 
Method IV Cold plasma was stirred with the addition of acetate 
buffer and sufficient 50 percent ethanol-water mixture to adjust the 
plasma to pH 7.2 and 15 percent ethanol over a period of two hours. 
The precipitate was removed by centrifugation and designated fraction 
A. The supernatant A was divided into two equal volumes and one 
volume was fractionated similar to Method III by adjusting to pH 6.9 
and 25 percent ethanol. The precipitate was removed and the pH of 
the resulting supernatant was measured and adjusted to 5.2 and the 
ethanol concentration to 18 percent. These two precipitates were com­
bined to give fraction B. The other volume of supernatant A was adjusted 
to pH 4.5 and 18 percent ethanol with stirring over a period of approxi­
mately two hours and then allowed to stand for eight to ten hours before 
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centrifuging to remove fraction C. 
Method V Fraction A and C were removed as described in Method 
IV. Supernatant C which was left at pH 4. 5 was adjusted to 40 percent 
ethanol by the addition of 95 percent ethanol with stirring over a two 
hour period. The precipitate was removed and designated as fraction 
D. 
Method VI Fraction A was removed as described in Method IV. 
Supernatant A was divided into two equal volumes and one volume 
adjusted to pH 5.2 and 25 percent ethanol by adding 50 percent ethanol 
and the acetate buffer with stirring over a 1. 5 hour period and then 
allowed to stand for 2.5 hours before centrifuging to remove fraction 
Ca. Sufficient 95 percent ethanol was added to supernatant Ca at pH 5.2 
to adjust the ethanol concentration to 40 percent over a two hour period. 
The precipitate was designated as fraction Da. The pH of the remaining 
volume of supernatant A was measured and adjusted to 6.8 with the 
acetate buffer and then the ethanol concentration increased to 30 per­
cent over a 1.5 hour period. The precipitate was removed 2.5 hours 
later and designated as fraction B-la. 
Fraction Ca was obtained at a more alkaline pH and a higher alcohol 
concentration as compared to fraction C in Method IV. Fraction Da 
was precipitated at pH 5.2 as compared to fraction D which was pre­
cipitated at pH 4.5. Fraction B-la was precipitated under similar 
conditions as fraction B-l in Method III. 
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Biological assays The tibia test as described by Greenspan et al. 
(22) with the modified procedure for staining the tibia (20) was used 
to assay the plasma fractions for growth hormone activity. 
Male rats which were commercially hypophysectomized at 21 days 
of age were used throughout this study. The animals were maintained 
on water, milk, oatmeal and a commercial rat feed. Administration 
of the plasma fractions was begun following a 12-16 day postoperative 
interval. 
Appropriate dilutions of the plasma protein fractions were made in 
sterile physiological saline. The animals received 0. 5 milliliter of 
the protein solutions twice daily by injecting intraperitoneally for 
four days. Twenty-four hours after the last injection, the animals were 
sacrificed with ether. One tibia was dissected free from soft tissue 
and split with a razor in the mid-sagital plane. The bone halves were 
stained immediately by washing in water for ten minutes, immersing 
in acetone for six minutes and washing in water again for three minutes. 
They were then placed in freshly prepared two percent silver nitrate 
for two minutes and then rinsed in water. While under water the bone 
halves were exposed to a strong light and when the calcified portions 
had become dark brown the bone half was removed to a microscope 
stage and the epiphyseal cartilage width was measured under low power 
by using a calibrated micrometer eyepiece. From 10 to 12 individual 
readings were made across the epiphysis. 
Electrophoretic studies Electrophoretic diagrams of the plasma 
fractions were obtained by zone electrophoresis in a starch bed. 
Commercial potato starch was prepared to use for the electrophoretic 
analysis as directed by Paigen (38). Sufficient distilled water was 
added to 300 grams of starch to bring the total volume to 700 milliliters. 
The starch and water mixture was stirred by hand to completely suspend 
all the starch. The supernatant fluid was siphoned off after allowing 
the starch to settle for 120 minutes. This washing procedure was re­
peated eight times with a gradual reduction in settling time to 45 min­
utes. The final product was washed with ethanol and dried over a 
steam plate. 
The trough used in this study was constructed of Leucite with dimen­
sions of 26x4x1 centimeters. Two strips of Whatman No. 3mm filter 
paper which were slightly wider than the trough and 20 inches in length 
were folded to give eight-layered pads about 2.5 inches long. These 
filter paper pads were held in place against each end of the trough by 
means of a rubber band. A slurry of starch (15-16 grams) and barbi­
turate buffer of pH 8. 6 and 0. 1 ionic strength was poured into the trough 
and the excess buffer was allowed to drain out through the end papers. 
The final thickness of the starch bed was approximately three millimeters 
The plasma fractions were dissolved in sufficient buffer to give a 
final concentration of 50 milligrams per milliliter. A O. 1 milliliter 
aliquot containing five milligrams of the fraction was injected with a 
hypodermic syringe into the starch in a narrow band perpendicular to 
the length of the bed. The trough was placed on the edges of the 
electrode vessels with the end papers dipping into the buffer. The 
papers served as conducting bridges between the starch bed and the 
electrode vessels. Carbon electrodes connected to leades from a direct 
current power supply were placed in the vessels containing the buffer 
at each end of the trough. The analysis was conducted at 4° C for 18 
hours with a potential of 250 volts. The trough was then removed from 
the electrode vessels and the excess buffer was allowed to drain from 
the bed through the end filter papers. While the starch was still wet, 
but firm, the bed was cut into one-fourth inch segments with a razor 
blade and each segment was eluted with two milliliters of saline. An 
aliquot of 0.4 milliliter of the eluate from each segment was used for 
protein determination with the Folin phenol reagent as described by 
Lowry et al. (34). The e le et r oph or eti c diagrams were prepared by 
plotting the optical density of the aliquot of each segment against the 
position of the segment in the starch bed. 
Results 
Bioassay of plasma fractions Fraction II plus III which was obtained 
by Method I was toxic when injected into hypophysectomized rats and 
could not be assayed for its growth hormone concentration. Felch and 
Nellor (13) indicated that a similar fraction of bovine plasma was toxic 
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to hypophysectomized rats, but the toxicity could be removed by ether 
extraction. Fraction II plus III was extracted with ether at room 
temperature for two hours but the toxicity could not be removed. 
The results of the assay of the plasma fraction obtained by Method 
II indicated that growth hormone normally present in plasma was not 
precipitated with plasma fraction E (Table 1). However, most of the 
bovine pituitary growth hormone which was added to the plasma could 
be recovered in this fraction. 
When plasma was fractionated by Method III, it appeared that the 
circulating growth hormone was concentrated in fraction B. The results 
of several assays of fraction B are shown in Table 2. These fractions 
contained a growth promoting substance which consistently increased 
tibial epiphyseal width. This factor was assumed to be growth hormone. 
The results of test 3 indicated that each component of fraction B con­
tained growth promoting activity with slightly more of the plasma growth 
hormone occurring in fraction B-2 than in fraction B-l. A greater 
stimulation in the tibial response occurred when the amount of the 
fraction injected was increased. 
The data shown in Table 3 indicate that fraction A which was the first 
fraction to be precipitated by these fractionation techniques did not contain 
growth hormone, since there was no growth of the epiphyseal cartilage 
resulting from the administration of this fraction. However, it is also 
possible that a growth response may have been masked by substances in 
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the plasma fraction which interfered with the assay. In the one test, 
fraction B which was compared with fraction C did not give a response 
as had been observed in other assays. Since fraction C could be re­
moved in a single step which would simplify the fractionation procedure, 
it was further investigated. The data in Table 3 show that all the plasma 
growth hormone was not concentrated in fraction C, since there was 
some activity remaining in fraction D. When the fractionation procedure 
was modified as in Method VI, most of the growth activity was isolaged 
in fraction Ca and very little was found in fraction Da. Fraction B-la 
which was precipitated at the isoelectric point of bovine pituitary growth 
hormone did not stimulate the growth of the epiphyseal cartilage. 
Table 1. Bioas say of plasma fraction E for growth hormone 
Group 
Amount of 
original 
pla smaa 
(ml. ) 
Number 
animals 
Tibial 
epiphyseal 
width 
micra* S. E. 
Fraction E 30 4 218.4*4. 0 
Fraction E +360 meg. 
growth hormone 30 3 319.5*5. 4 
360 meg. growth hormone 0 4 354.5±15.1 
Saline 0 4 228.4*4. 0 
aPlasma sample was taken from a Holstein calf. 
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Table 2, Bioassay of plasma fractions from Method III for growth hormone 
Amount of Tibial 
Weight of original epiphyseal 
fraction plasma Number width 
Test Fraction gm./100ml. (ml. ) animals micra*S. E. 
B 1.85 34 3 247. 016. 8 
Saline 0 3 202.4Î20.7 
B 2.09 25 3 257.5i23.4 
B 2.09 50 3 261.1*5. 9 
B 2.09 75 3 274.8+4. 0 
Saline 0 3 222.0*6. 0 
B -1 0.72 30 4 240.014. 5 
B-2 2.44 30 4 255. 2±9. 5 
B 3.40 30 4 275.6 *9.6 
Saline 0 4 218.8 ±-13.7 
& Plasma sample was taken from a one-year old Jersey bull. 
^Plasma sample was taken from two two-year old Hereford steers. 
cPlasma sample was taken from four one-year old Hereford steers. 
Electrophoretic analysis The electrophoretic diagrams of the various 
plasma fractions obtained by Methods III, V and VI are shown in Figures 
1, 2 and 3. In these diagrams, optical density of the aliquot of each seg­
ment as developed by the Folin reagent is plotted against starch bed 
position. All the fractions appeared to be relatively complex and each 
contained some of the major plasma proteins. In general, fraction A, 
the first fraction to be removed, was composed of gamma-globulins, 
beta-globulins, fibrinogen and very small amounts of alpha-globulins and 
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Table 3. Bioassay of plasma fractions from Method IV, V and VI for 
growth hormone 
Amount of Epiphyseal 
Fraction­ Weight of original cartilage 
ation fraction plasma Number width 
method Fraction gm. /100 ml. (ml. ) animals micra*S. E. 
B 2.58 35 4 213.1 *6.2 
IVa C 3.27 35 4 237.5 *4.4 
Saline 0 4 213.2*0.8 
A 2.49 30 2 184.7 *3.4 
vb C 3. 31 30 3 244.6*2. 5 V D 2.72 30 3 223.7 *12.4 
Saline 0 3 197.6 *3. 1 
A 2.90 40 3 208.0*6.4 
ca 2.84 40 2 260.0*10.4 
VIe Da 1.90 40 2 234.7*7. 9 
B - l a  0.81 40 3 227.2*4. 2 
Saline 0 3 222.9±9.5 
aPlasma sample taken from a three-year old Hereford cow. 
^Plasma sample taken from two two-year old Hereford steers. 
c Plasma sample taken from two one-year old crossbred steers and 
two one -year old crossbred heifers. 
albumin. Fractions B and C were electrophoretically similar which would 
be expected since these two fractions were precipitated under similar con­
ditions. These two fractions contained most of the alpha-globulin and 
some of the albumin proteins. Electrophoretic analysis indicated that 
fractions Ca and C were similar, however, fraction Da contained less of 
the beta-globulins as compared to fraction D. 
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Discussion. 
The results of these studies indicated that plasma growth hormone can 
be concentrated by low-salt ethanol plasma fractionation techniques. The 
most desirable feature of such a method for estimating plasma growth 
hortnone is the use of the rat tibia test as the assay criterion. However, 
the use of such a method for assaying the circulating hormone is limited 
by several factors. The most serious limitation is the amount of the 
fraction which can be injected into the assay animals. With some of the 
fractions studied, the fraction from 30 milliliters of plasma was near 
the maximum amount which could be administered to the rats. Therefore, 
it would be desirable to have a plasma fraction more concentrated in 
growth hormone. From this consideration alone it appears that fraction 
Ca would be more desirable than fraction C for estimating the plasma 
concentration of growth hormone. In these studies it was found impossible 
to concentrate all of the plasma growth hormone into a single fraction 
which could be assayed with the tibia test. 
It has been shown that adrenocorticotropic hormone will reduce the 
tibial response of growth hormone and that thyrotropic hormone may act 
synergistically with growth hormone (20). Since these plasma fractions 
were not assayed for these interfering hormones the results of these 
assays might be modified; however, the interpretation of the data might 
not be much different. Nevertheless these hormones do interfere with 
the tibia assay to such an extent that it would be necessary to have some 
Figure 1. Electrophoretic diagrams of plasma fractions obtained 
by Method III 
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strength 0. 1, veronal buffer at 250 volts for 18 hours 
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Figure 2. Electrophoretic diagrams of plasma fractions obtained 
by Method Y 
Zone electrophoresis on starch in a pH 8.6, ionic 
strength 0. 1, veronal buffer at 250 volts for 18 hours 
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Figure 3. Electrophoretic diagrams of plasma fractions obtained 
by Method VI 
Zone electrophoresis on starch in a pH 8.6, ionic 
strength 0.1, veronal buffer at 250 volts for 18 hours 
34 
FRACTION A 
FRACTION C 
FRACTION 
6 18 36 
SEGMENT No. 
35 
estimate of their presence before this fractionation method could be 
extensively used as a quantitative estimate for plasma growth hormone. 
All of the plasma fractions which contained growth hormone activity 
had an electrophoretic component which was similar to the alpha - globulins. 
Fraction A which had no detectable growth hormone activity had no alpha-
globulin component. This suggests that the plasma growth hormone may 
be associated with the alpha-globulins. Hei;ken skjold and Gemzell (27) 
found that I^l labeled pituitary growth hormone appeared with the alpha-
globulins in electrophoretic fractionations. 
Two observations in these studies suggested that the circulating hor­
mone may be chemically different from the hormone isolated from the 
pituitary gland. First, it was observed that when pituitary growth hor­
mone was added to plasma, most of the growth activity was recovered 
in fraction E, but none of the circulating hormone was concentrated in 
this fraction. Secondly, advantage of the fact that proteins are least sol­
uble at their isolectric point is often used in protein fractionations and 
has been used in pituitary growth hormone isolation. The isolated bovine 
pituitary hormone has been found to have an isolectric point of pH 6. 8 
(32), but none of the circulating hormone precipitated at pH 6.8 as the 
ethanol concentration increased from 15 to 30 percent which were the 
conditions to precipitate fraction B-la. It appears that the circulating 
hormone may precipitate at a lower pH (e.g. pH 4. 5 in fraction C and 
pH 5.2 in fraction Ca)as compared to the pituitary hormone which will 
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precipitate at pH 6. 8 (32). The chemical difference may be nothing more 
than a conjugation of the pituitary hormone with a plasma protein. Such 
a conjugation of a hormone with plasma proteins has been proposed for 
other hormones. A protein-protein interaction might be sufficient to 
alter the chemical properties of growth hormone in blood. The above 
proposal may also explain why Gemzell et al. (19) could recover only 
25 percent of the pituitary growth hormone added to plasma. As more 
refined plasma fractionation techniques and more sensitive assay methods 
for growth hormone are developed, it appears very possible that the 
chemical nature of the circulating hormone may be established. 
An Immunochemical Assay Technique for ' Measuring Growth 
Hormone in Bovine Serum 
The antigenicity of purified bovine pituitary growth hormone was 
established by Hayashida and Li (25) and these same authors suggested 
that an immunochemical technique might be developed as an assay tech­
nique for growth hormone in biological fluids. The use of immunochem­
ical techniques for estimating either antibody or antigen concentration 
is not a new research technique (5); however, the use of serological 
methods in hormone research is a new application. Read and Stone (42) 
have used an immunological assay for human growth hormone in serum. 
These workers used the hemagglutination inhibition technique and found it 
to be sufficiently sensitive to assay serum. Li et al. (33) used the quanti­
tative precipitin test to assay for the growth hormone content of individual 
37 
human pituitaries and observed that the immunochemical assay technique 
gave slightly higher values as compared to the,biological assays which 
were run concurrently. The precipitin test could measure 100 percent 
of growth hormone added to serum but there was no observable reaction 
with the growth hormone present in serum from normal or acromegalic 
patients. 
In all the previous studies, no attempt has been made to use the 
complement fixation reaction to estimate the amount of reaction between 
growth hormone and its specific antibody. In the present investigation, 
studies have been made to evaluate the use of the complement fixation 
reaction and the application of this immunochemical technique for esti­
mating the growth hormone concentration of bovine serum. 
Methods 
The antiserum to bovine pituitary growth hormone was produced in 
young albino male rabbits with an average weight of 2.7 kilograms. The 
animals were maintained on commercial rabbit pellets3- supplemented 
with fresh greens and carrots. 
The required amount of antigen^ was dissolved in saline and added to 
a Manufactured by Ralston Purina, St. Louis, Missouri. 
^The Somar, Lot No. M208, used in these studies was kindly supplied 
by Armour and Company, Chicago, Illinois. A purified bovine growth 
hormone preparation, Lot No. L580, 835-0-16 was supplied by Merck 
and Company, Rah way, New Jersey. 
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an equal volume of Freund's adjuvant (17)a. As indicated in the review 
of literature, the adjuvant appears essential for antibody production by 
growth hormone. Before injection into the animals , the saline, hormone 
and adjuvant were aspirated in and out of a syringe until a uniform 
suspension was obtained. If a drop of the suspension would not spread 
when allowed to fall on the surface of water, mixing was considered 
complete. 
The rabbits were initially injected intravenously with 2.5 milligrams 
of growth hormone dissolved in saline. The next day, 10 milligrams 
of growth hormone was suspended in the complete adjuvant and five 
milligrams injected subcutaneously and five milligrams intraperitoneally. 
Each week for the following three weeks, 10 milligrams of growth hor­
mone was suspended in the incomplete adjuvant and injected intraper­
itoneally into each animal. The antibody titer was checked by the pre­
cipitin test a week after the last injection and all animals were then 
bled by cardiac puncture. The antiserum was preserved by storing in 
the frozen state. Antibody titers were maintained by booster injections 
of 10 milligrams of hormone in incomplete adjuvant each month. 
The antiserum was absorbed by adding bovine serum which had 
been diluted 1:10 in saline. The diluted serum was added in small 
volumes to the antiserum and the mixture was then placed in the 
aComplete and incomplete adjuvants were purchased from Difco 
Laboratories, Detroit, Michigan. 
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refrigerator for four to five hours before the precipitate was removed 
by centrifugation. The process was repeated until no further precipitation 
occurred. 
The precipitin ring tests were performed by adding the required 
amount of antigen in 0.2 milliliter of saline to three-millimeter test 
tubes. The growth hormone was added by serial dilution so the con­
centration decreased by one-half in succeeding tubes. With the aid of 
a long needle and syringe, 0.05 milliliter of antiserum was carefully 
layered under the antigen solution. The tubes were incubated at room 
temperature and readings were made 30 minutes later. A positive 
test consisted of a line of precipitation at the junction of the antigen 
solution and antiserum. The control tubes contained antiserum 
layered under saline or normal rabbit serum layered under the antigen 
solution. 
Complement is widely used as an indicator for immunological re­
actions since it has the capacity to combine with many antigen-antibody 
complexes. In this manner, immune reactions can be detected when 
other visible reactions such as precipitation or agglutination are absent. 
The complement fixation test depends on two properties of complement: 
1) the binding of complement by an antigen-antibody complex and 
2) the lysis of sensitized red blood cells. The test is usually per­
formed in two steps. First, a specified dose of complement and anti­
body are allowed to react with the antigen. Second, sensitized sheep 
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cells are added and the mixture is again incubated. If there is an 
antigen-antibody reaction, complement will be fixed and not available 
to lyse sensitized red cells. The reaction can be easily followed by 
measuring the amount of hemoglobin released by the lysis of the red 
cells. 
The complement fixation reactions were conducted as described by 
Kabat and Mayer (29) with slight modifications. Hemolysin and lyoph-
ilized guinea pig complement were purchased commerciallya. Red 
blood cells were obtained by drawing sheep blood into an equal volume of 
Alsever's solution and storing at 4° C in the refrigerator. The cells 
were stored at least four days before being used in the hemolysin re­
action. Shortly before use, the cells were washed until free of serum 
and until the resulting supernatant solution was colorless. The cells 
were washed in a saline buffer containing 8.5 grams NaCl, 0. 1 gram 
MgClz, 0.575 gram barbituric acid and 0. 375 gram sodium barbital 
per liter. This buffer was used for washing the cells and all dilutions 
for the complement fixation tests. A five percent suspension of red 
blood cells was made by diluting the washed cells in the buffer described 
above. The cells were then sensitized by mixing the red cell suspension 
with an equal volume of properly diluted hemolysin for 10 minutes at 
37° C. After sensitization, the cells were kept in an ice bath until used. 
aBa et o -anti s he ep hemolysin and guinea pig complement were pur­
chased from Difco Laboratories, Detroit, Michigan. 
In the initial studies, the complement was diluted in saline, however in 
subsequent studies, bovine serum was used as the diluent for complement. 
The effect of varying the concentration of complement was studied and 
found to be of importance in this investigation. Kabat and Mayer (29) 
suggested using 30 minutes for complement fixation by the antigen-
antibody reaction and 30 minutes for the hemolysis reaction, but in 
these studies one hour fixation and one hour hemolysis were more 
satisfactory. 
The details of a typical assay are as follows: Known amounts of 
growth hormone were added to 15 milliliter conical centrifuge tubes in 
0.2 milliliter volumes„ Unknown samples were also diluted to 0.2 
milliliter. Next, 0.05 milliliter of antiserum was added to each tube 
with mixing, followed by the addition of 0. 1 milliliter of the diluted 
complement with mixing. The tubes were incubated for one hour in a 
water bath maintained at 37° C. After the incubation period, the sen­
sitized red blood cells were added and mixed. The tubes were again 
incubated for one hour at 37° C with frequent shaking to keep the cells 
suspended. Sufficient saline was added to bring the volume of each tube 
to three milliliters before centrifuging down the intact red blood cells. 
After centrifuging, an aliquot of the supernatant was analyzed for the 
amount of hemolysis by reading its optical density in a Beckman Model-B 
spectrophotometer at 520 or 550 millimicrons as suggested by Kabat 
and Mayer (29). Later work indicated that reading the optical density 
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at 535 millimicrons in the Beckman Model-B spectrophotometer would 
be the most sensitive. 
Results 
The bovine growth hormone antiserum was found to react with as little 
as three micrograms of bovine growth hormone as indicated by the pre­
cipitin ring test. Absorbing the antiserum with bovine serum did not 
appear to reduce the antibody titer of the antiserum towards growth hor­
mone (Table 4). The bovine growth hormone was not found to give a 
visible reaction with normal rabbit serum. 
The unabsorbed antiserum gave a positive precipitin ring test with 
0.2 or 0.1 milliliter of bovine serum; however, when the antiserum 
was absorbed with bovine serum there was no visible reaction with bovine 
serum in the precipitin ring test (Table 5). Hayashida and Li (25) observed 
a reaction between growth hormone antiserum and serum gamma-globulin, 
but the antibodies to the serum gamma-globulins could be absorbed leaving 
an antiserum specific for growth hormone. These results suggest that 
a similar reaction was occurring in this study, since absorbing the anti­
serum removed the antibodies which were giving the visible precipitin 
reaction with bovine serum. The antisera produced with either the Armour 
or Merck growth hormone preparations could not be differentiated by the 
precipitin tests and both gave similar reactions with bovine serum. 
The results in Table 6 show that the growth hormone antiserum and 
growth hormone preparation will fix complement as shown by the decreased 
optical density of the supernatant solution, which indicates that less red 
cells were lysed in tubes containing growth hormone and its antiserum. 
When the individual components of the reaction were studied separately, 
it was found that neither the antiserum nor growth hormone would fix 
complement. The specificity of the antiserum is shown in Table 7. The 
unabsorbed antiserum was found to react in a similar manner with plasma 
fractions A and D which had been found to contain very little if any growth 
hormone activity by the tibia assay in the previous studies. When the 
antiserum was absorbed, the cross reacting antibodies appeared to be re­
moved. Hay a s hi da and Li (25) had reported that their growth hormone 
antiserum contained antibodies to lactogenic hormone which could be re­
moved. The results of these studies indicate that the absorbed antiserum 
was specific for growth hormone. 
To further check the specificity of the complement fixation test, the 
effect of bovine serum upon guinea pig complement was studied. The data 
in Table 8 show that bovine serum does not contain factors which will fix 
complement. The data also indicate that the presence of bovine serum 
does not affect the hemolysis reaction. 
A series of studies were conducted to investigate the effect of various 
factors upon the sensitivity of this immunochemical assay technique. The 
effects of complement concentration and amount of red blood cells on the 
regression coefficients of the standard curves are shown in Tables 9 and 10. 
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The regression coefficients were calculated for the range of zero to 0.2 
micrograms of growth hormone. As the complement was diluted, the test 
become more sensitive; however, diluting the complement more than 1:40 
gave unsatisfactory results. It appears the 1:40 dilution of complement 
was the most satisfactory dilution of the source of complement used in 
this study. It was calculated by use of the von Krougb equation (29) that 
the 1:30 dilution of complement contained approximately 1.3, 50 percent 
units of complement per 0. 1 milliliter. Increasing the concentration of 
Table 4. Precipitin ring tests with bovine growth hormone antiserum 
Antiserum Growth hormone (meg. ) 
Saline 100 50 25 12 6 3 1.5 0.75 
Unabsorbed — +• -fr 4- 4 4- 4- ± ± 
Absorbed — +• 4  4  4  4 - 4  
Table 5. Reaction of bovine growth hormone antiserum with bovine serum 
using the precipitin ring test 
Antiserum Bovine serum (ml. ) 
Saline 0.2 0.1 
Unabsorbed 
Absorbed 
4-
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Table 6. Complement fixation by unabsorbed growth hormone antiserum, 
bovine growth hormone and combination of antiserum and 
hormone 
Treatment Optical density 
at 520 millimicrons 
Control (no complement) 0.04 
C omple me nta 0.25 
Complement and 0.05 ml. antiserum 0.25 
Complement and 10 meg. growth hormone 0.24 
Complement and 10 meg. hormone and antiserum 0.02 
aGuinea pig complement diluted 1:40 in saline and 0. 1 ml. added to each 
tube. 
complement decreased the sensitivity of the assay over the range of 
growth hormone concentration studied. In general, it was observed that 
as the amount of red blood cells increased the test was more sensitive 
(Table 10). If the optical density of the supernatant solution were read 
at 535 millimicrons it was slightly more sensitive than if optical density 
were measured at 520 or 550 millimicrons. 
A representative standard curve which was obtained by using 0. 1 
milliliter of 1.40 complement, 0.5 milliliter of 2.5 percent sensitized 
red blood cells and reading optical density at 550 millimicrons is shown 
in Figure 4. The data for the curve are shown in Table 11 and the 
statistical analysis in Table 12. The data indicate that the sum of squares 
due to regression was highly significant at less than the one percent level 
of probability and there was no significant deviation from linearity over 
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Table 7. Specificity of growth hormone antiserum in complement 
fixation reactions 
Antiserum Treatment Optical density 
at 520 millimicrons 
Unabsorbed^ 
Absorbed^ 
Absorbed^ 
Control (no antigen) 0.29 
1 meg. plasma fraction A 0.04 
1 meg. plasma fraction D 0.05 
1 meg. growth hormone 0.05 
Control (no antigen) 0.31 
1 meg. plasma fraction A 0.28 
1 meg. plasma fraction D 0.34 
1 meg. ovine lactogenic hormone 0.35 
1 meg. growth hormone 0. 14 
Control (no antigen) 0.35 
10 meg. plasma fraction A 0.33 
10 meg. plasma fraction D 0.32 
10 meg. ovine lactogenic hormone 0.36 
aGuinea pig complement diluted 1:40 in saline and 0. 1 ml. added to each 
tube. 
^Guinea pig complement diluted 1:40 in bovine serum and 0. 1 ml. added 
to each tube. 
the range from zero to 0. 15 microgram of growth hormone. The re­
gression equation calculated by the method of least squares was found to 
be Y : 0.460 - 1.43 X, where Y = optical density and X: micrograms of 
growth hormone. The calculation of the index of precision (3) is shown in 
Table 12 and was found to be 0. 007. 
Several standard curves which were established under similar con­
ditions had regression coefficients varying from -1.29 to -2.45 while the 
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Table 8. Effect of bovine serum on complement fixation in the absence 
of growth hormone and antiserum 
Test Treatment3- Optical density 
1 Control 0.29 
0. 1 ml. serum 0.26 
2 Control 0.25 
0. I ml. serum 0.28 
aGuinea pig complement diluted 1:40 in saline and 0. 1 ml. added to each 
tube. 
Table 9. Effect of amount of complement on sensitivity of immunochemical 
assay 
Dilution of complement3 Regression coefficient 
IS. E.b 
1:20 -0.258*0. 044 
1:30 -0.491*0.078 
1:40 -0. 7 1810. 107 
aGuinea pig complement diluted in bovine serum and 0. 1 milliliter added 
to each tube. 
^Standard error of the regression coefficient. 
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Table 10. Effect of amount of red blood cells on sensitivity of 
immunochemical assay 
V olume of red blood 
cells per tubea 
Regression coefficient 
ÎS. E.b 
ml. 
0. 3 
0.4 
0.5 
-0.532*0. 046 
-0. 656*0. 057 
-0.781±0. 041 
aA concentration of 2. 5 percent sensitized red blood cells was used. 
Guinea pig complement diluted 1:40 in bovine serum and 0. 1 milliliter added 
to each tube. 
index of precision varied from 0.009 to 0.029 for these curves. Until 
more is known about the factors which influence the assay, a standard 
curve should be established for each test for the best quantitative estimate 
of the amount of growth hormone in an unknown sample. 
The complement fixation assay technique was used to estimate the 
amount of growth hormone in 0.2 milliliters of serum from cattle of 
different ages and from two lambs (Tables 13 and 14). The analysis of 
the serum samples which had been obtained from individual animals in­
dicated that the technique was sensitive enough to estimate the growth 
hormone concentration of whole serum. 
Discussion 
The results of these studies have demonstrated that immunochemical 
^Standard error of the regression coefficient. 
Figure 4. A standard growth hormone curve obtained from 
complement fixation by growth hormone and its 
homologous antiserum 
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Table 11. Effect of various levels of growth hormone upon complement 
fixation 
Growth hormonea Optical density^ 
mcg. 
0 0.46 
0.025 0.43 
0. 050 0.39 
0.100 0.30 
0.150 0.25 
aGuinea pig complement diluted 1:40 in bovine serum and 0. 1 
milliliter added to each tube. 
^Average value of two tubes. 
techniques are sensitive enough to measure small amounts of growth 
hormone when a specific antiserum is used; however, the precipitin re­
action could not be used to measure the amount of growth hormone present 
in bovine serum. 
The complement fixation reaction which is considered to be consider­
ably more sensitive than the precipitin reaction was found to detect as 
little as 0. 025 microgram of bovine growth hormone. This technique is 
based upon the fact that complement is absorbed by antigen-antibody com­
plexes. Since many antigen-antibody complexes absorb complement, it 
is imperative that the antiserum be specific for growth hormone. The 
curves which describe the course of complement fixation by a constant 
level of antibody with increasing amounts of antigen at constant complement 
5 2  
Table 12. Statistical analysis of data on the effect of levels of growth 
hormone on complement fixation 
1. Analysis of variance 
Source of variation d.f. Mean 
square 
Total 9 
Levels 4 0.0151 
Regression (1) 0.0595 
Remainder (3) 0.0003 
Error 5 0.0001 
2. Regression analysis 
Sxx = 0.0290 
b =-0.4155 1—1.433 
0 . 0 2 9 0  
V(b) = 0.0001 = 0. 003448 
0 . 0 2 9 0  
b =-1.43310. 059 
Index of precision =0.01 = 0.007 
1.433 
Sxy = -0.4155 
595.0a 
3. 0 
""Significant at less than the one percent level of probability. 
Table 13. Estimation of growth hormone in bovine serum by complement 
fixation 
Serum Growth hormone 
meg. /100 ml. 
One year-old heifer 
Two year-old heifer 
Mature cow 
73.8 
35.6 
5.0 
5 3  
Table 14. Estimation of growth hormone in ovine serum by complement 
fixation 
Serum Growth hormone 
meg. /100 ml. 
Lamb 1 81.5 
Lamb 2 108.6 
concentration are characterized by an initial steep segment with a gradual 
tapering off as the equivalence zone ratios are approached. When the 
level of antibody is in excess, complement fixation is highly responsive to 
minute changes in antigen concentration. In this study, the amount of com­
plement fixation was linear over the range from zero to 0. 2 microgram of 
growth hormone and was sensitive enough to measure the growth hormone 
concentration of bovine and ovine serum. 
The assay as developed in this study appears to be specific for growth 
hormone but it should be checked with homogeneous preparations of other 
pituitary hormones to definitely establish its specificity. The specificity 
studies in this investigation indicated that the absorbed antiserum did not 
react with a bovine gamma-globulin fraction or ovine lactogenic hormone. 
The reaction of the antiserum with the ovine serum demonstrates that the 
bovine and ovine growth hormone are antigenically related as observed by 
Hayashida and Li (23). 
The sensitivity and precision of the immunochemical assay appears to 
compare favorably with other growth hormone assay techniques (44). 
Most of the biological methods available are considered to be deficient 
in one or more respects: inconvenient because of nature of test, dur­
ation of treatment, amount of material required or lacking in specificity 
and precision. If the described immunochemical assay proves to be 
specific for growth hormone it would be the most desirable assay tech­
nique considering the above criteria. It is not known if changes in the 
structure of the growth hormone molecule which destroy its biological 
properties would also destroy its ability to react with the growth hormone 
antibody. Until more is known about the relationship of the chemical 
structure of proteins and their biological actions, the biological assay 
will still be very useful in hormone research. 
For convenient measuring of minute amounts of growth hormone in 
biological fluids the immunochemical assay technique appears to be one 
of the best techniques available. The work of Hayashida and Li (23) in­
dicated that human or monkey growth hormone would not react with the 
antiserum for bovine growth hormone. If one used an antiserum for the 
growth hormone of a given species it should be possible to use the com­
plement fixation reaction to estimate the amount of growth hormone from 
that species, which would allow the adaptation of such a technique for 
clinical purposes as well as a research tool with domestic animals. 
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Comparison of the Rat Tibia Assay and the Immunochemical 
Assay of Growth Hormone in Bovine Plasma 
The results of the two methods studied have been presented and 
discussed previously. The results indicated that the circulating growth 
hormone was being measured by both methods but it appeared necessary 
to compare the two methods qualitatively and quantitatively to fully deter­
mine the value of each. 
Methods 
In the first study, blood samples were taken from mature cows, two 
year -old heifers and nine month-old heifers. The animals were not 
pregnant or in lactation. Blood samples from two animals in each age 
group were pooled and the plasma fractionated by Method V. Plasma 
fractions C and D were combined and an amount equivalent to 20 milliliters 
of original plasma was injected into each hypophysectomized rat over the 
4 day period. A weighed amount of the fraction from each of the three 
groups was dissolved in saline to give the original volume from which 
that amount of the fraction had been taken and 0. 3 milliliter of this dilution 
added to each tube for the immunochemical assay. 
Blood samples were also taken from four mature cows which were 
over seven years of age and their suckling bull calves which were about 
ten weeks of age. The plasma samples from two of the animals in each 
age group were pooled and fractionated by Method VI. An amount of 
plasma fraction Ca equivalent to 40 milliliters was administered to each 
assay rat over the 4 day injection period. A given amount of the fraction 
was restored to the volume from which it had been obtained and 0. 3 
milliliter used to assay for growth hormone by the immunochemical 
te chnique. 
The rat tibia assays and the immunochemical assays were conducted 
as previously described. Armour Somar Lot No. M208 was used for the 
standard growth hormone curve with the tibia assay. 
Results 
The results of the biological assay of fraction C and D and Ca ^iay be 
seen in Tables 15 and 16. Fraction C and D from each of the three age 
groups increased the epiphyseal cartilage width as compared with the saline 
control but there was more stimulation when the fraction was taken from 
younger animals. Fraction Ca from each of the four groups of animals 
increased the cartilage width as compared to the saline control; however, 
there were no differences between age groups. The standard curve with 
epiphyseal cartilage width plotted against total dose of 10 to 100 micro­
grams of growth hormone is shown in Figure 5. The statistical data for 
this standard curve can be found in Table 17. 
The rat tibia assay and the immunochemical assay of fraction C and D 
gave similar results except in the case of the calves and two year-old 
heifers (Table 18). The fact that both methods gave rather similar 
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Table 15. Biological assay of plasma fraction C+D with the rat tibia 
test 
Amount of Weight Tibial 
original of epiphyseal 
plasma fraction Number width 
(ml. ) gm. /100 ml. animals micra*S. E. 
Mature cows 20 5.44 5 231. 9*3.3 
2 year heifers 20 6.46 5 244.7 + 7.5 
9 month heifers 20 6.53 5 253. 9±3.4 
Saline 
> 
5 218. 3±8.3 
Table 16. Biological assay of plasma fraction Ca from cows and calves 
with the rat tibia test 
Amount of Weight Tibial 
original of epiphyseal 
plasma fraction Number width 
(ml. ) gm. /100 ml. animals micra*S. E. 
Calf plasma 40 2.47 9 264.9*4.7 
Calf plasma 40 2. 15 9 294.2 ±5. 4 
Cow plasma 40 3. 10 9 292.414.2 
Cow plasma 40 2.67 9 300.815. 3 
100 meg. growth 
hormone 5 383. 0 *20. 2 
50 meg. growth 
hormone 5 343.5+24.9 
20 meg. growth 
hormone 5 315.7*10.7 
10 meg. growth 
hormone 5 277. Oil 1.2 
Saline 5 225.8 *10.2 
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Table 17. Statistical analysis of data from standard growth hormone 
treatments 
1. Analysis of variance 
Source of variation 
Total 
Dose 
Regression 
Remainder 
Error 
2. Regression analysis 
Sxx = 2.896 Sxy = 292.65 
b = 292.65 = 101.05 
2 . 8 9 6  
V(b) = 1653. 18 = 570. 01 
2 .896  
b = 101. 05*23. 87 
Index of precision = 40. 659 = 0.402 
101. 05 
^Significant at less than the one percent level of probability. 
quantitative estimates of the amount of growth hormone present in fraction 
C+D is of most importance for comparing the two methods. 
The growth hormone concentration of plasma fraction Ca was estimated 
with both methods as shown in Table 19. The rat tibia assay and immuno­
chemical assay were consistent and gave similar results. The interesting 
observation was the fact that the immunochemical assay of serum from 
d.f. Mean F 
square 
19 
3 10007.69 
(1) 29573.20 17.8 5a 
(2) 224.93 0. 14 
16 1653.18 
Figure 5. Log dose - response curve for standard growth hormone 
treatments using tibia test 
400 h 
0 L 
I O 20 
GROWTH 
50 
HORMONE ADMINISTERED (  meg.)  
1 0 0  
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Table 18. Comparison of the rat tibia test and immunochemical assay 
for growth hormone in bovine plasma fraction C+D 
Blood donor Tibia testa Immunochemical 
meg. growth hormone/100 ml. 
9 month calves 35.5 29.7 
2 year heifers 26.5 33.4 
Mature cows 13.5 11.7 
^Quantity of growth hormone-estimated by assuming a tibial stimulation 
of 5 microns per microgram of growth hormone between 0 and 10 micro­
grams (Table 16). 
Table 19. Comparison of the rat tibia test and immunochemical assay for 
growth hormone in bovine serum 
Blood 
donor 
Fraction Ca 
Tibia test Immunochemical 
Whole serum 
Immuno che mi cal 
Calves 
Cows 
07 
09 
017 
019 
C-10 
126 
C-35 
C-37 
1 8 . 0  
35.0 
40.8 
33.8 
meg. growth hormone/ 100 ml. 
21.9 
28.4 
39.3 
28.4 
49.0 
8 0 . 0  
104.5 
107.5 
1 1 2 . 0  
107.5 
90.5 
119.5 
64.5 
106.0  
109.8 
105.0 
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individual animals gave similar trends in growth hormone concentration 
as the rat assay or immunochemical analysis of the plasma fraction. 
Considering only the immunochemical data, it was calculated that about 
30 percent of the circulating hormone was concentrated in plasma fraction 
Ca, which seems rather low considering that very little growth hormone 
was found in other plasma fractions. It is possible that some growth 
hormone might have been destroyed by the fractionation technique. 
Discussion 
The fact that similar amounts of growth hormone were estimated by 
the immunochemical technique as by the rat tibia assay is further evidence 
which suggests that the immunochemical technique may be a reliable and 
precise method for assaying growth hormone. Since the immunochemical 
technique is much more sensitive, it is readily adaptable for assaying 
serum for circulating growth hormone. 
These data are too limited to make conclusive interpretations on factors 
which might affect the concentration of growth hormone in the blood of 
beef cattle, but in the one assay with non-pregnant, non-lactating cows 
and heifers it appeared that the growth hormone concentration in blood 
decreased with age. Similar results were reported by Nellor (37) for 
the growth hormone concentration in blood of dairy bulls. However, no 
differences due to age were observed when blood was taken from lactating 
mature cows and their young calves. Contopoulos and Simpson 
6 3  
(8) observed an increased growth hormone concentration in rats during 
pregnancy and it is interesting to speculate as to whether the increased 
endocrine activity during pregnancy and lactation may also result in 
increased growth hormone activity. If the assay technique used in these 
studies can be applied to a relatively large number of animals, the 
factors which affect the concentration of growth hormone in blood can 
be investigated more thoroughly. 
GENERAL DISCUSSION 
The results of these studies indicate that immunochemical techniques 
can be used to measure the growth hormone content of serum. Read and 
Stone (42) reported that a hemagglutination-inhibition technique would 
detect the minute amount of growth hormone in human serum, but Li 
et al. (33) reported that the precipitin reaction was not sensitive enough 
to assay serum. The complement fixation reaction is another immuno­
logical technique which has been used to estimate the extent of the anti­
body and hormone reaction. The hemagglutination technique is one of the 
most sensitive immunological techniques available, but requires some­
what more laboratory manipulation and more time to obtain the final 
results. The most desirable feature of the complement fixation assay is 
the ease with which the standard can be prepared and the ease of com­
paring unknowns with the standard. The most serious limitation of the 
complement fixation assay appears to be that several factors other than 
complement and hemolysin may cause hemolysis of red blood cells. If 
the laboratory conditions are rigorously controlled, these factors should 
not interfere with the assay. 
The fractionation of plasma and assaying the fractions in rats have 
been attempted by other workers but was not developed as a method for 
estimating the growth hormone content of plasma. The results of the 
fractionations in this study indicated that it was not possible to concentrate 
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all the plasma growth hormone in a fraction small enough to be assayed 
in rats. The immunochemical technique indicated that approximately 
30 percent of the plasma growth hormone was concentrated in one plasma 
fraction. The rather limited success of the fractionation methods merely 
indicates that more needs to be known about the nature of the circulating 
growth hormone before it can be quantitatively concentrated. 
It was of great interest to observe that the immunochemical and the 
rat tibia assay gave very similar quantitative results when used to assay 
several plasma fractions.. This general agreement of the two techniques 
helps substantiate the use of the immunochemical technique in future 
growth hormone studies. 
The fact that very little is known about the factors which affect the 
level of circulating growth hormone makes such a technique a valuable 
research tool. At this time it is possible only to discuss some of the 
probable applications of growth hormone studies to domestic animals. 
Many studies of a more general nature need to be made initially to 
determine what the different physiological states, such as age, pregnancy 
or lactation, may have upon the hormone concentration. It has been 
assumed, and there is some experimental evidence to support the theory, 
that growth hormone concentration in biological fluids decreases with 
age. There are data to show that the amount of growth hormone per unit 
of pituitary tissue does not decrease with age (1) (2), but since the ratio 
of pituitary tissue to body tissue decreases as an animal matures the 
amount of pituitary growth hormone per unit of body tissue decreases with 
age. The one observation in this study indicated that plasma growth hor­
mone decreased with age; however, another test indicated no difference 
between mature lactating cows and their suckling calves. The effects 
of lactation as well as age on plasma growth hormone need to be inves -
tigated further. 
The effects of nutrition, especially protein, on the endocrine system 
have received some attention with interesting but rather inconclusive 
results. It appears possible that protein nutrition may have quite a pro­
found effect upon the synthesis and release of pituitary hormones, since 
these hormones are protein molecules with specific structures essential 
for biological activity. The importance of nutrition undoubtedly is not 
the plane of nutrition (1) but differences may be readily apparent between 
deficient and adequate nutrition. If nutritional deficiencies affect the en­
docrine system as is apparent in laboratory animals (45), the interesting 
question is how well the system recovers when adequate nutrition is 
resumed. The effects of protein nutrition on circulating growth hormone 
as well as other hormones would be interesting investigations. 
The ability of animals and humans to grow is controlled to a large 
extent by heredity. The inherent ability of swine to make rapid gains is 
apparently reflected in the concentration of growth hormone in the pituitary 
glands and presumably related to the amount of circulating growth hormone 
(2). This suggests a very practical application of a serum assay technique 
for predicting the future performance of domestic animals for purposes 
of selection. The ability to estimate an animal's rate of gain would also 
be very useful for allotment of experimental animals. Accurate pre­
dictions of future performance will probably require some knowledge of 
other hormones involved with growth in addition to growth hormone. 
There has been general acceptance of the gain-stimulating feed 
additives in livestock production, but the physiological mode of action 
of these materials is not clearly understood. Some data suggest that the 
hormone feed additives may be altering the endocrine system (6) (47). 
Techniques which could be used to assay serum for the various hormones 
involved with growth would be important methods for studying the physio­
logical effects these materials may have on the endocrine system. 
The real importance of the results obtained in this study is not the 
technique developed because techniques change and improve as new facts 
become available. Neither is it so important that growth hormone can be 
measured in blood. Of most importance is the fact that the quantitative 
measurement of pituitary hormones in biological fluids is not an im­
possibility, because these results give encouragement that the other hor­
mones will also be measured in the not too distant future. The valuable 
contributions to the field of endocrinology and its subsequent effects upon 
growth and other physiological functions will be made when the complex 
pattern of the hormones can be evaluated thoroughly. 
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SUMMARY 
Two methods were developed for demonstrating the presence of growth 
hormone in bovine blood. 
Plasma growth hormone was sufficiently concentrated into a plasma 
fraction with a low-salt ethanol method so it could be assayed with the 
tibia test in hypophysectomized rats. The plasma fraction which con­
tained growth hormone activity was precipitated at pH 5.4 to 4.5 and 
electrophoretic analysis revealed that most of the plasma alpha-globulin 
protein was also precipitated in this fraction. The use of this method for 
quantitatively measuring plasma concentration of growth hormone was 
limited, since all of the plasma hormone could not be concentrated into 
a single plasma fraction suitable for biological assay in the experimental 
assay rats. 
An immunochemical assay technique based upon complement fixation 
was used to detect as little as 0.025 microgram of purifie d b ovine pituitary 
growth hormone. The specificity of the assay was studied by replacing 
growth hormone with several serum fractions or ovine lactogenic hormone 
in the complement fixation reaction. Based upon the results of these 
studies, the assay was considered specific for growth hormone. Standard 
curves which were established by plotting the optical density of the hemo­
globin released during the hemolysis reaction against quantities of 
purified growth hormone were linear over the range of zero to 0.15 
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microgram of hormone. This immunochemical assay technique had 
sufficient precision and sensitivity to measure the circulating growth 
hormone present in 0.2 milliliter of bovine serum. 
To further check this new growth hormone assay technique, the 
immunochemical assay and the rat tibia assay were compared by assaying 
a plasma fraction for growth hormone. Within the limits of experimental 
error, both methods gave similar quantitative estimates of growth hor­
mone concentration. 
Rather limited application of the immunochemical technique indicated 
that growth hormone concentrations in serum from non-lactating and non­
pregnant mature cows, two-year old heifers and one-year old heifers 
were 5,0, 35.6 and 73.8 micrograms per 100 milliliters of serum re­
spectively. The analysis of serum samples from mature lactating cows 
and their ten-week old bull calves indicated that there were no differences 
in the concentration of circulating growth hormone due to age. 
Although the immunochemical assay appeared specific in these studies, 
it should be further investigated. It appears that such a technique will 
have many applications in future studies concerned with factors affecting 
growth of beef cattle. 
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